|
|
Volumn 8, Issue 1, 2002, Pages 29-35
|
|
Pharmacokinetics, tolerability, and fructosamine-lowering effect of a novel, controlled-release formulation of α-lipoic acid
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACARBOSE;
ANTIDIABETIC AGENT;
FRUCTOSAMINE;
GLIBENCLAMIDE;
GLIMEPIRIDE;
GLIPIZIDE;
GLUCOTIZE;
INSULIN;
METFORMIN;
PERCOSE;
SULFONYLUREA DERIVATIVE;
THIOCTIC ACID;
TROGLITAZONE;
ADULT;
AGED;
AREA UNDER THE CURVE;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED RELEASE FORMULATION;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG CAPSULE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
FRUCTOSAMINE BLOOD LEVEL;
HEMATOLOGY;
HUMAN;
KIDNEY FUNCTION;
LIVER FUNCTION;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
RANDOMIZED CONTROLLED TRIAL;
TABLET FORMULATION;
TASTE DISORDER;
TIME;
|
|
EID: 0036161589
PISSN: 1530891X
EISSN: None
Source Type: Journal
DOI: 10.4158/ep.8.1.29 Document Type: Article |
|
Times cited : (59)
|
|
References (26)
|
